🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 16 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/03/2021 | 164,82 | 168,82 | 161,48 | 168,35 | +2,54% | 4,45% | 370.800 |
| 24/03/2021 | 165,75 | 166,69 | 162,98 | 164,18 | -0,45% | 2,24% | 187.400 |
| 23/03/2021 | 168,25 | 169,42 | 163,24 | 164,93 | -2,04% | 3,67% | 279.400 |
| 22/03/2021 | 169,13 | 169,60 | 166,61 | 168,36 | -1,03% | 1,77% | 220.400 |
| 19/03/2021 | 170,26 | 172,87 | 168,87 | 170,11 | -0,14% | 2,35% | 746.200 |
| 18/03/2021 | 169,27 | 173,43 | 167,47 | 170,35 | -0,48% | 3,52% | 501.100 |
| 17/03/2021 | 165,14 | 171,40 | 163,51 | 171,17 | +2,76% | 4,78% | 486.400 |
| 16/03/2021 | 164,10 | 167,12 | 162,32 | 166,57 | +1,51% | 2,93% | 338.300 |
| 15/03/2021 | 159,45 | 164,31 | 155,86 | 164,10 | +2,88% | 5,30% | 275.600 |
| 12/03/2021 | 159,07 | 159,76 | 155,71 | 159,50 | +0,43% | 2,55% | 319.600 |
| 11/03/2021 | 162,08 | 162,16 | 158,47 | 158,82 | -0,54% | 2,28% | 282.300 |
| 10/03/2021 | 160,00 | 161,34 | 157,88 | 159,68 | +0,42% | 2,16% | 287.800 |
| 09/03/2021 | 161,39 | 164,33 | 158,55 | 159,01 | -0,67% | 3,58% | 505.200 |
| 08/03/2021 | 166,44 | 166,44 | 159,00 | 160,09 | -2,59% | 4,47% | 332.500 |
| 05/03/2021 | 161,47 | 164,77 | 159,02 | 164,34 | +2,49% | 3,56% | 502.200 |
| 04/03/2021 | 163,91 | 166,65 | 159,54 | 160,34 | -1,76% | 4,34% | 558.200 |
| 03/03/2021 | 164,80 | 168,99 | 160,87 | 163,21 | -2,03% | 4,93% | 280.600 |
| 02/03/2021 | 170,73 | 173,12 | 166,25 | 166,59 | -2,73% | 4,02% | 184.100 |
| 01/03/2021 | 167,20 | 173,03 | 166,78 | 171,27 | +2,45% | 3,74% | 305.000 |
| 26/02/2021 | 169,79 | 170,26 | 165,99 | 167,18 | -0,96% | 2,51% | 339.900 |
| 25/02/2021 | 174,38 | 174,38 | 165,24 | 168,80 | -2,82% | 5,24% | 401.500 |
| 24/02/2021 | 169,08 | 181,14 | 169,08 | 173,70 | +0,77% | 7,13% | 467.100 |
| 23/02/2021 | 173,57 | 174,12 | 167,97 | 172,38 | -1,11% | 3,54% | 263.400 |
| 22/02/2021 | 175,09 | 178,68 | 173,66 | 174,31 | -0,31% | 2,87% | 460.900 |
| 19/02/2021 | 169,74 | 175,95 | 169,74 | 174,85 | +3,26% | 3,66% | 320.600 |
| 18/02/2021 | 171,90 | 171,90 | 168,23 | 169,33 | -1,98% | 2,13% | 231.800 |
| 17/02/2021 | 169,72 | 177,93 | 169,38 | 172,75 | +1,80% | 5,04% | 434.700 |
| 16/02/2021 | 171,67 | 171,74 | 167,75 | 169,69 | +1,22% | 2,32% | 242.500 |
| 12/02/2021 | 169,00 | 169,71 | 166,55 | 167,64 | -1,11% | 1,87% | 159.600 |
| 11/02/2021 | 167,39 | 171,28 | 166,83 | 169,53 | +0,58% | 2,66% | 254.700 |